HemaCare Corporation has expanded its global capabilities through a strategic distribution agreement in China with MT-Biological Science and Technology Co. Ltd. HemaCare distribution agreements enable partners to actively provide support to customers. Researchers are able to obtain both fresh and cryopreserved cells through direct shipments from HemaCare’s FDA-registered donor collection center, as well as its cell isolation laboratory in California, while receiving customer service and technical support in their native language through specially trained representatives locally in their region. HemaCare also provides ongoing technical training and marketing support to assist global partners in providing best in class service and support.